Acutus Medical to Announce Third Quarter 2020 Financial Results
October 29 2020 - 4:01PM
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it
will release its financial results for the third quarter of 2020
after market close on Thursday, November 12, 2020. In conjunction
with the release, Acutus will host a conference call and webcast at
2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its
financial results and recent highlights.
Interested parties may access the live call via telephone by
dialing (833) 570-1131 for domestic callers or (914) 987-7078 for
international callers, using conference ID: 6990208. The live
webinar of the call may be accessed by visiting the Events section
of the Acutus investor relations website at ir.acutusmedical.com. A
replay of the webinar will be available shortly after the
conclusion of the call and will be archived on the company’s
website following the earnings call.
About Acutus Medical,
Inc. Acutus Medical is an arrhythmia management company
focused on improving the way cardiac arrhythmias are diagnosed and
treated. Acutus is committed to advancing the field of
electrophysiology with a unique array of products and technologies
which will enable more physicians to treat more patients more
efficiently and effectively. Through internal product development,
acquisitions, and global partnerships, Acutus has established a
global sales presence delivering a broad portfolio of highly
differentiated electrophysiology products. Acutus Medical’s goal is
to provide its customers with a complete solution for
catheter-based treatment of cardiac arrhythmias in each of its
geographic markets. Founded in 2011, Acutus is based in Carlsbad,
California.
Investor Contact:Caroline CornerWestwicke ICRD:
415-314-1725Caroline.corner@westwicke.com
Holly WindlerM: 619-929-1275media@acutusmedical.com
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Apr 2023 to Apr 2024